What is everyone's opinion on
speculative buying at this price...?
Not exact matches
Echelon has a
Speculative Buy rating and a CA$ 3.25 per share
price target on Immunovaccine Inc., whose stock is currently trading
at around CA$ 2.24 per share.
Last month the European Central Bank vice president said Bitcoin was a «
speculative asset» where investors were «taking that risk of
buying at such high
prices».
Echelon has a Top Pick status,
Speculative Buy recommendation and $ 2.75 per share
price target on Immunovaccine, whose stock is currently trading
at $ 1.63 per share.
Spot trading puts in place a contract to trade an agreed amount of currency
at the advertised spot rate or
buy / sell
price enabling
speculative gains.
Vitor Constancio said developments in bitcoin's
price make it «a
speculative asset by definition,» adding, «Investors are taking that risk of
buying at such high
prices.»